Solid Biosciences Inc. — Director's Dealing 2018

Nov 20, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2018-11-16

Reporting Person: Quiroz Jorge Armando (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-16	Common Stock	S	100	$34.90	Disposed	268242	Direct

Footnotes

F1: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2018.